YOLFTbeta
Australian Clinical Labs Ltd

Australian Clinical Labs Ltd

ACL · AU · Healthcare / Diagnostics & Research

3.35AUD+0.02 (+0.60%)

Price History

Full chart

Market Stats

Previous Close3.33
Open3.37
Day Range3.30 – 3.37
52-Week Range1.77 – 2.99
Volume222.04K
Market Cap520.39M
P/E (TTM)23.25
Forward P/E15.08
EPS0.12
Dividend Yield4.66%
Beta0.83
50-Day Avg2.69
200-Day Avg2.35

About

Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers cardiac testing, gastroenterology, haematology, chemical pathology, antenatal testing, serology and microbiology, cervical screening, commercial drug and alcohol testing, STI Testing, veterinary pathology, molecular cancer services, clinical trials pathology, advanced genetic testing, functional pathology, histopathology and cytopathology, CPD education programs for clinicians, and allergy and immunology services. It also provides workplace services, environmental screening, and clinical trial services. The company offers its services under the SunDoctors, SouthernSun Pathology, Specialised Trials, BeFunctional Labs, and Gribbles Veterinary Pathology brands. It serves doctors, patients, and corporate clients. The company was founded in 2015 and is headquartered in Clayton, Australia.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Gregory John Horan
  • Employees4.50K
  • Headquarters1868-1892 Dandenong Road, Clayton, VIC, Australia, 3168, Australia
  • Websitehttps://www.clinicallabs.com.au

Leadership

  • Mr. Gregory John HoranGroup CEO & Executive Director
  • Mr. Matthew CordingleyChief Financial Officer
  • Mr. Anthony FriedliChief Operating Officer
  • Mr. Sean JacksonChief Information Officer
  • Mr. Joe GeranNational Marketing Director
  • Associate Prof. Tony LandgrenNational Medical Director & Chief Pathologist
  • Mr. Chris BrownlowChief Executive Officer of New South Wales & Australian Capital Territory
  • Ms. Shae SeymourChief Risk Officer & CEO of WA/SA/NT
  • Ms. Eleanor Padman B.A., FCISCompany Secretary
  • Mr. Darren McKeeChief Executive Officer of Victoria

Financials

Income Statement

Currency: AUD2017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue339.77M376.09M445.89M487.53M641.31M989.30M692.10M689.73M741.27M729.52M
Growth (%)-+10.69%+18.56%+9.34%+31.54%+54.26%-30.04%-0.34%+7.47%-1.58%
Cost of Revenue57.68M265.85M313.89M402.49M119.58M207.59M126.08M551.28M470.41M579.31M
Gross Profit282.09M110.24M132.00M85.04M521.73M781.71M566.02M138.45M270.86M150.21M
Gross Margin83.02%29.31%29.60%17.44%81.35%79.02%81.78%20.07%36.54%20.59%
Operating Expense302.66M116.15M139.57M69.51M399.12M514.03M509.95M81.55M088.72M
Operating Income-20.57M-5.91M-7.58M15.53M122.61M267.68M56.07M56.91M270.86M61.49M
Operating Margin-6.05%-1.57%-1.70%3.19%19.12%27.06%8.10%8.25%36.54%8.43%
EBITDA-8.06M5.41M19.31M107.50M196.67M372.75M184.93M169.65M81.36M196.84M
EBITDA Margin-2.37%1.44%4.33%22.05%30.67%37.68%26.72%24.60%10.98%26.98%
Net Income-24.03M-9.01M-10.52M41.26M60.37M178.24M35.90M23.93M32.43M23.71M
Net Income Margin-7.07%-2.40%-2.36%8.46%9.41%18.02%5.19%3.47%4.37%3.25%
Interest Expense-3.65M3.94M16.57M21.97M11.75M13.87M17.04M18.37M18.45M
Interest Expense % of Total Revenue-0.97%0.88%3.40%3.43%1.19%2.00%2.47%2.48%2.53%

Balance Sheet

Currency: AUD2017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets120.89M119.06M153.61M366.05M474.70M628.04M578.91M593.06M574.84M592.66M
Total Liabilities106.77M113.60M126.19M297.06M392.79M395.49M406.24M415.30M402.86M442.90M
Total Equity14.12M5.46M27.42M68.99M81.90M232.44M172.42M177.53M171.35M149.52M
Cash7.04M6.87M4.13M34.85M35.23M26.37M19.95M26.14M21.44M24.73M
Total Debt48.26M53.52M56.00M221.21M294.26M262.38M316.32M308.90M290.38M337.40M
Net Debt41.23M46.65M51.87M186.36M259.03M236.00M296.36M282.76M268.94M312.67M

Cash Flow

Currency: AUD2017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow4.60M4.69M1.11M101.74M153.86M284.09M143.68M159.59M182.80M163.31M
Investing Cash Flow-11.91M-8.86M-13.37M-9.96M-6.08M-72.04M-12.18M-7.25M-8.89M-9.28M
Financing Cash Flow13.37M3.97M9.52M-60.92M-147.37M-220.91M-137.88M-146.14M-178.74M-150.69M
Capital Expenditure7.46M8.63M14.36M9.38M9.51M21.25M6.93M6.50M8.41M9.58M
Free Cash Flow-2.85M-3.94M-13.25M92.36M144.36M262.83M136.75M153.09M174.39M153.73M
Dividends Paid----42.00M24.22M96.88M19.95M24.95M24.59M
FCF to OCF-62.02%-84.00%-1191.55%90.78%93.82%92.52%95.17%95.92%95.40%94.14%
Dividend Paid to FCF----29.09%9.21%70.85%13.03%14.30%16.00%

Earnings

Report DateMay 14, 2021Aug 26, 2021Feb 23, 2022Aug 9, 2022Nov 30, 2022Feb 19, 2023Feb 25, 2025Aug 26, 2025
EPS Estimate0.000.000.000.000.000.000.00-
EPS Actual0.280.020.650.240.000.130.060.12
Surprise--------
Timing-Pre-marketAfter-hoursAfter-hours-After-hours-After-hours

Key Statistics & Ratios

Market Cap520.39M
Enterprise Value838.66M
Trailing P/E23.25
Forward P/E15.08
Price / Sales0.71
Price / Book3.52
EPS0.12
Book Value0.808
Revenue (TTM)736.15M
Gross Profit (TTM)280.68M
EBITDA81.88M
Profit Margin3.22%
Operating Margin11.22%
Return on Equity14.93%
Return on Assets7.45%
Shares Outstanding186.52M
Shares Float171.74M
Beta0.83
Dividend Yield4.66%
Dividend Rate0.13
Payout Ratio103.41%

Dividends

20262×
0.09Sep 2, 20260.04Mar 12, 2026
20252×
0.09Sep 1, 20250.04Mar 27, 2025
20242×
0.09Sep 4, 20240.03Mar 28, 2024
20232×
0.07Sep 14, 20230.07Mar 27, 2023
20222×
0.41Aug 23, 20220.12Mar 25, 2022